POST Online Media Lite Edition



 

Topic: TEVA

96 results were found.

SaskPower selects proponent for new 100 megawatt solar facility near Estevan - January 23, 2024

Teva and Glenmark to pay over quarter of a billion dollars to resolve price fixing charges - August 23, 2023

Teva settles price-fixing claims with Kentucky for $1.41m - June 13, 2023

Teva settles U.S. opioid claims - June 9, 2023

Chemours, DuPont and Corteva offer more than $1 billion to settle forever chemicals claims - June 5, 2023

Tevano to acquire green lithium technology company Aqua-Eo - February 24, 2023

Settlements totaling $20.1 billion with CVS, Walgreens, Walmart Pharmacies, Teva and Allergan for opioid crisis - January 16, 2023

Illinois announces $6.6 billion settlement with opioid makers Teva and Allergan - November 30, 2022

Commission sends objections to Teva over misuse of patent system, disparagement of rival multiple sclerosis medicine - October 10, 2022

FTC sues pesticide Syngenta and Corteva for price-fixing - October 4, 2022

AG Shapiro secures preliminary agreement with Teva for $4.25 billion - August 2, 2022

Teva reaches $75 million agreement with West Virginia to settle opioid-related claims - May 26, 2022

Texas AG Paxton reaches another opioid settlement for Texas, $225 million against Teva - February 10, 2022

Teva fueled opioid addiction in New York, jury finds - December 30, 2021

Antitrust: Commission opens investigation into possible anticompetitive conduct of Teva - March 8, 2021

New Mexico: Lawsuit filled against Gilead, Bristol-Myers Squibb, Teva in HIV/AIDS drugs case - March 4, 2021

Commission fines Teva and Cephalon €60.5 million for delaying entry of cheaper generic medicine - November 30, 2020

U.S. files false claims act complaint against Teva Pharmaceuticals alleging illegal kickbacks - August 18, 2020

Teva Pharmaceutical Q4 earnings $683 million - February 12, 2020

Unredacted information shows unbelievable greed of Teva Pharmaceuticals - February 11, 2020

Teva agrees to pay $54m fine to settle whistleblower lawsuit - January 7, 2020

Teva Pharmaceuticals Q3 revenues $4,264 million - November 7, 2019

Court unseals documents revealing how Teva contributed to opioid crisis - August 29, 2019

Teva says CFO Michael McClellan will step down - August 7, 2019

Teva Pharmaceutical Industries Q2 adjusted earnings beat estimates - August 7, 2019

Teva to pay Oklahoma $85 million to settle opioid claims - May 26, 2019

Teva revenues down 15% - May 2, 2019

Teva Pharmaceutical Q4 net loss $2.94 billion - February 14, 2019

Teva Pharmaceutical Industries to pay Illinois $135m fraud settlement - January 14, 2019

John Wood Group wins big contract with TEVA in Germany - May 23, 2018

Teva Pharmaceutical Industries profit falls in Q4 - February 8, 2018

Teva agrees with workers on closing Jerusalem tablet plant - January 3, 2018

Teva: We must lay off 14,000 workers - December 14, 2017

Teva to launch generic Viagra in U.S. - December 12, 2017

Teva reportedly considering cutting up to 10,000 jobs - December 8, 2017

Teva Q3 earnings down 26% - November 2, 2017

Teva Pharma to sell some women's health assets for $1.38 billion - September 18, 2017

Teva appoints Kåre Schultz as CEO - September 12, 2017

Teva Pharmaceutical Industries posts 15% fall in Q2 earnings - August 3, 2017

Teva to close plant, lay off 500 in Hungary - May 22, 2017

Teva Q1 net income $580 million - May 12, 2017

Teva profit increases 30 percent in Q4 - February 13, 2017

Teva names Yitzhak Peterburg interim president and CEO - February 7, 2017

Judge says Mylan may make generics, Teva says no way - January 31, 2017

Court says Eli Lilly may block Teva's generic - January 12, 2017

Teva completes £603 million sale of UK and Ireland Actavis assets - January 9, 2017

Teva sees 2017 EPS to be $4.90 - $5.30 - January 6, 2017

Teva to pay $519 million to settle bribery charges - December 23, 2016

Teva: Dipankar Bhattacharjee new CEO of Global Generic Medicines - December 6, 2016

Teva expects Q4 revenues to be $6.2-$6.5 billion - December 6, 2016

Teva Q3 GAAP gross profit $2.8 billion - November 16, 2016

Teva to sell UK and Ireland Actavis assets in £603m deal - October 5, 2016

Teva completes acquisition of Allergan's Anda - October 4, 2016

48-state, $125 million settlement with Teva's Cephalon - August 4, 2016

Teva Pharma to buy Allergan's Anda distribution for half a billion - August 3, 2016

Teva Pharma completes Actavis Generics acquisition - August 2, 2016

Impax Labs to buy generics from Teva and Allergan for $586 million - June 22, 2016

Sagent Pharma to buy ANDA Portfolio from Teva Pharma in $40m deal - June 17, 2016

Teva Pharma to halt sales of migraine patch after reports of burns - June 13, 2016

Dr. Reddy’s to buy product portfolio from TEVA for U.S. for $350m - June 13, 2016

Teva Pharmaceutical Q1 revenues down 3 percent - May 10, 2016

Teva sees close of $40.5 billion Allergan generics deal by June - March 16, 2016

EU approves acquisition of Allergan Generics by Teva with conditions - March 10, 2016

Teva Pharmaceutical Industries Q3 revenues $4.8 billion - October 30, 2015

Teva Pharma to acquire Rimsa in $2.3 billion deal - October 1, 2015

Teva secures $33.75 billion for acquisition of Allergan's generic business - July 31, 2015

Teva Q2 revenues $5 billion, down 2% - July 31, 2015

Teva Pharma Q2 revenues down 2% to $4.97 billion, guidance up to EPS $5.15 to $5.40 - July 27, 2015

Teva withdraws from Mylan, will buy Allergan Generics in $40.5 billion transaction - July 27, 2015

Mylan wants to block Teva, Teva wants to block Mylan - July 24, 2015

ANI Pharmaceuticals buys 22 generic drugs from Teva for $25 million - July 14, 2015

Teva completes purchase of 4.61% interest in Mylan - June 20, 2015

Teva switches legal counsel after Mylan challenge - June 10, 2015

Teva to Mylan: Our offer is strong and serious - June 9, 2015

Mylan: Teva's stake buy violates U.S. anti-trust rules - June 2, 2015

Teva buys 1.35% of Mylan's stock - May 29, 2015

Teva completes $3.5 billion acquisition of Auspex Pharmaceuticals - May 6, 2015

Mylan sues Teva's law firm Kirkland & Ellis - May 4, 2015

Teva is losing nerves: Mylan should stop mudslinging - April 30, 2015

Mylan: We are not giving our valuable stock for low-quality Teva shares - April 27, 2015

Teva willing to give $31 billion for Mylan - April 21, 2015

Teva to buy Auspex Pharma for $3.5 billion - March 30, 2015

Teva elects Yitzhak Peterburg as chairman - November 27, 2014

Teva names president and CEO of Global Generic Medicines Group - June 3, 2014

Teva names Erez Vigodman as president and CEO - January 10, 2014

Teva chairman Moshe Many to step down - December 11, 2013

Yoo Suk Hong CEO of Teva-Handok - April 10, 2013

Teva names CEO of Teva Seiyaku, Japan - April 8, 2013

Teva appoints Arie Belldegrun to board of directors - February 11, 2013

Teva announces changes to executive leadership team - November 6, 2012

Itzhak Krinsky named chairman of Teva Japan and Teva South Korea - September 13, 2012

Teva announces new appointments - August 6, 2012

Intevac adds Thomas Rohrs to the board of directors - October 7, 2010

Intevac: Christopher Smith EVP of emerging markets - August 31, 2010

Intevac adds John F. Schaefer to the board - June 18, 2010

Teva Pharmaceutical Industries: Philip Frost new chairman of the board - March 9, 2010


Back home